Lipogenesis from n-butyrate in colonocytes. Action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis.
Cell membranes of colonic epithelial cells (CEC) in ulcerative colitis show structural abnormalities which are specific to the disease and which suggest impaired lipogenesis in CECs. Lipogenesis from [1-14C]-n-butyrate, the chief oxidative fuel of colonic epithelial cells, was measured in isolated CECs under control conditions, with or without glucose and in the presence of mercaptoacetate, a major reducing agent in the colonic lumen. Glucose significantly (p < 0.01) stimulated lipogenesis from [1-14C]-butyrate which was reversed by 5 mM mercaptoacetate. Mercaptoacetate significantly diminished CEC thiolase activity (EC 2.3.1.9). 5-Aminosalicylic acid reversed the adverse effects of mercaptoacetate in the saponifiable fraction of extracted lipids. Changes in lipogenesis due to colonic luminal reducing agents would affect the barrier function of CECs a feature relevant to the disease process of ulcerative colitis.
Roediger
W E
WE
University of Adelaide, Department of Surgery, Queen Elizabeth Hospital, Australia.
Kapaniris
O
O
Millard
S
S
D000636:Aminosalicylic Acids / Q000494:pharmacology*; D000818:Animals; D002087:Butyrates / Q000378:metabolism*; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000503:physiopathology*; D003106:Colon / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008055:Lipids / Q000096:biosynthesis*; D019804:Mesalamine; D051381:Rats; D017207:Rats, Sprague-Dawley; D013864:Thioglycolates / Q000494:pharmacology*
D000636:Aminosalicylic Acids; D002087:Butyrates; D008055:Lipids; D013864:Thioglycolates; D019804:Mesalamine; C017487:2-mercaptoacetate